Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

107.80
Delayed Data
As of Jun 15
 +0.74 / +0.69%
Today’s Change
70.76
Today|||52-Week Range
153.99
-15.15%
Year-to-Date
Alnylam Reports Positive Data on Lumasiran in Renal Disease
Jun 11 / Zacks.com - Paid Partner Content